Dose Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Suppression for Intermediate Risk Prostate Cancer: Outcomes From the NRG Oncology/RTOG 0815 Randomized Trial. Int J Radiat Oncol Biol Phys. 2021 Nov 01; 111(3S):S1.